Myrobalan Therapeutics’ $24 Million Series A Funding Round

Goodwin represented Myrobalan Therapeutics on the matter. Myrobalan Therapeutics announced its $24 million Series A financing. The round was led by Co-win Ventures, with participation from…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Sonia Carcano

Author: Sonia Carcano

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here